Aura Biosciences, Inc. AURA Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s operating lease liabilities (total)?
- Aura Biosciences, Inc. (AURA) reported operating lease liabilities (total) of $16.99M in Q1 2026.
- How has Aura Biosciences, Inc.'s operating lease liabilities (total) changed year-over-year?
- Aura Biosciences, Inc.'s operating lease liabilities (total) decreased by 7.9% year-over-year, from $18.44M to $16.99M.
- What is the long-term trend for Aura Biosciences, Inc.'s operating lease liabilities (total)?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s operating lease liabilities (total) has grown at a 105.5% compound annual growth rate (CAGR), from $975K to $17.38M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.